Juvenile localized scleroderma
© 2024. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature..
Juvenile scleroderma, often referred to as juvenile localized scleroderma or "morphea", is a rare inflammatory disease of the skin and skin-related structures, accompanied by local sclerosis and tissue fibrosis. Depending on the clinical manifestation, four different subtypes can be defined: limited, generalized, linear, and mixed. To prevent possible sequelae of the disease, the diagnosis should be made as early as possible and therapy should be initiated at specialized centers in multiprofessional pediatric and dermatologic collaboration. In this review, we present the main clinical, laboratory, and therapeutic characteristics of juvenile localized scleroderma and summarize recommendations.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:75 |
|---|---|
| Enthalten in: |
Dermatologie (Heidelberg, Germany) - 75(2024), 3 vom: 04. Feb., Seite 208-213 |
| Sprache: |
Deutsch |
|---|
| Weiterer Titel: |
Zirkumskripte Sklerodermie im Kindesalter |
|---|
| Beteiligte Personen: |
Strauss, Timmy [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Clinical practice guidelines |
|---|
| Anmerkungen: |
Date Completed 26.02.2024 Date Revised 26.02.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00105-023-05293-5 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367313022 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367313022 | ||
| 003 | DE-627 | ||
| 005 | 20240229154928.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240119s2024 xx |||||o 00| ||ger c | ||
| 024 | 7 | |a 10.1007/s00105-023-05293-5 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1306.xml |
| 035 | |a (DE-627)NLM367313022 | ||
| 035 | |a (NLM)38240812 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a ger | ||
| 100 | 1 | |a Strauss, Timmy |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Juvenile localized scleroderma |
| 246 | 3 | 3 | |a Zirkumskripte Sklerodermie im Kindesalter |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 26.02.2024 | ||
| 500 | |a Date Revised 26.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2024. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature. | ||
| 520 | |a Juvenile scleroderma, often referred to as juvenile localized scleroderma or "morphea", is a rare inflammatory disease of the skin and skin-related structures, accompanied by local sclerosis and tissue fibrosis. Depending on the clinical manifestation, four different subtypes can be defined: limited, generalized, linear, and mixed. To prevent possible sequelae of the disease, the diagnosis should be made as early as possible and therapy should be initiated at specialized centers in multiprofessional pediatric and dermatologic collaboration. In this review, we present the main clinical, laboratory, and therapeutic characteristics of juvenile localized scleroderma and summarize recommendations | ||
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Clinical practice guidelines | |
| 650 | 4 | |a Juvenile localized scleroderma | |
| 650 | 4 | |a Morphea | |
| 650 | 4 | |a Progression | |
| 650 | 4 | |a Sequelae | |
| 700 | 1 | |a Günther, Claudia |e verfasserin |4 aut | |
| 700 | 1 | |a Brück, Normi |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Dermatologie (Heidelberg, Germany) |d 2022 |g 75(2024), 3 vom: 04. Feb., Seite 208-213 |w (DE-627)NLM330027379 |x 2731-7013 |7 nnns |
| 773 | 1 | 8 | |g volume:75 |g year:2024 |g number:3 |g day:04 |g month:02 |g pages:208-213 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00105-023-05293-5 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 75 |j 2024 |e 3 |b 04 |c 02 |h 208-213 | ||